|
⚲
|
| Keyboard |
| Warmuth Markus
✚
|
|
|---|---|
| CIK # | 0001855643 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001855643] | |
| 4 | [0001855643] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monte Rosa Therapeutics Inc | |
| Warmuth Markus |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-03-02 | Sell | 5,466 | $17.92 | 97,951 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 3,707 | $23.24 | 86,151 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 1,450 | $23.88 | 34,626 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-07 | Sell | 309 | $24.57 | 7,592 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 10,135 | $15.17 | 153,748 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-02 | Grant | 90,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 406,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 575,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2025-01-02 | Grant | 128,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 346,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Grant | 472,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2022-03-01 | Grant | 315,600 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2021-06-23 | Grant | 141,623 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2021-04-12 | Grant | 538,517 | $0.00 |